Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: A controlled trial

Diabetic Medicine

Volumn 13, Issue 2, 1996, Pages 156-159

  Chantelau, E ^a,b   Tanudjaja, T ^a   Altenhofer F ^a   Ersanli, Z ^a   Lacigova, S ^a   Metzger, C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Diabetesambulanz MNR Klinik   (Germany)

Author keywords

Complications; Diabetes mellitus; Diabetic foot; Gangrene; Infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; PLACEBO;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOOT ULCER; FOREFOOT; GANGRENE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; WOUND CARE;

ADMINISTRATION, ORAL; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLAVULANIC ACID; CLAVULANIC ACIDS; DIABETIC FOOT; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLINS;

EID: 0029917224     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199602)13:2<156::AID-DIA59>3.0.CO;2-U     Document Type: Article

References (13)

1. Jeffcoate WJ, Finch RG. Choice of antibiotic therapy in diabetic foot lesions. In: Bakker K, Nieuwenhuijzen Kruseman AC, eds. The Diabetic Foot. Proceedings of the First International Symposium on the Diabetic Foot. Amsterdam: Elsevier/Excerpta Media, 1991: 98-107.
2. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994; 331: 854-860.
3. Jenkins SA, Richardson PC, Elliott J, Young RJ, Ganguli LA, Keany MGL, et al. A role for fine needle aspiration in microbological assessment of diabetic foot ulcers (Abstract). Diabetologia 1991; 34 (suppl. 2): A162.
4. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G, et al. Unsuspected osteomyelitis in diabetic foot ulcers - diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinolone. J Am Med Assoc 1991; 266: 1246-1251.
5. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990; 150: 790-797.
6. Harkless LB, Lavery LA, Felder-Johnson K. Diabetic ulceration - classification and management. In: Bakker K, Nieuwenhuijzen Kruseman AC, eds. The Diabetic Foot. Proceedings of the First International Symposium on the Diabetic Foot. Amsterdam: Elsevier/Excerpta Medica, 1991: 78-82.
7. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. J Am Med Assoc 1995; 273: 721-723.
8. Grayson ML, Gibbons GW, Habershaw GM, Freeman DV, Pomposelli FB, Rosenblum BI, et al. Use of ampicillin/sulbactam versus imipenem/cilastin in the treatment of limb-threatening foot infections in diabetic patients. Clinical Infectious Diseases 1994; 18: 683-693.
9. Foulston J, Edmonds M, Pike B. An objective assessment of the healing rate of diabetic foot lesions by photography and morphometry (Abstract). Diabetic Med 1987; 4: 379.
10. Chantelau E, Breuer U, Leisch AC, Tanudjaja T, Reuter M. Outpatient treatment of unilateral diabetic foot ulcers with 'half shoes'. Diabetic Med 1993; 10: 267-270.
11. Martin M. Dynamisches Wundheilungsprofil des venösen ulcus cruris. VASA 1994; 23: 228-233.
12. Altman DG. Statistics and ethics in medical research. How large a sample? Br Med J 1980; 281: 1336-1338.
13. Bessman AN, Sapico FL. Infections in the diabetic patient: The role of immune dysfunction and pathogen virulence factors. J Diab Comp 1992; 6: 258-262.